ReachMD

Episodes 1-15 of 92

• • 

    

    Lisa Nodzon PhD, ARNP, AOCNP

    Peer

  0

  

  RestartResume

  Looking Out for Neutropenia in Chronic Lymphocytic Leukemia

• • 

    

    Lisa Nodzon PhD, ARNP, AOCNP

    Peer

  0

  

  RestartResume

  Key Considerations for Initiating a Chronic Lymphocytic Leukemia Therapy
• 0

  

  RestartResume

  The Power of Comprehensive Care & Music Therapy in MS

• • 

    

    Vincent Hsu, MD

    Peer

  0

  

  RestartResume

  How to Talk About Pneumococcal Disease With Your Adult Patients at Increased Risk

• • 

    

    Vincent Hsu, MD

    Peer

  1

  

  RestartResume

  CDC Recommendations for Pneumococcal Disease in Adults Under Age 65 With Certain Chronic Conditions

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Robin K. Dore, MD

    Peer

  • 

    

    Wendy Simmons, PA-C

    Peer

  2

  

  RestartResume

  Navigating the Prior Authorization Process: Expert Perspective for a Postmenopausal Osteoporosis Therapy

• • 

    

    Javeed Siddiqui, MD, MPH

    Peer

  0

  

  RestartResume

  Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Robert J. Mentz, MD

    Peer

  • 

    

    Bill Colucci, MD

    Peer

  2

  

  RestartResume

  What Are the Risks and Outcomes Associated With Worsening Heart Failure Events?

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Robert J. Mentz, MD

    Peer

  • 

    

    Bill Colucci, MD

    Peer

  2

  

  RestartResume

  Which Signaling Pathways Are Disrupted During a Worsening Heart Failure Event?

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Robert J. Mentz, MD

    Peer

  • 

    

    Bill Colucci, MD

    Peer

  2

  

  RestartResume

  How Do We Identify Patients With Chronic HFrEF Experiencing Worsening Heart Failure Events?
• 0

  

  RestartResume

  A Look at the Immunogenicity of MSI-H Tumors

• • 

    

    Richard K. Bogan, MD

    Peer

  1

  

  RestartResume

  Pathophysiology of Obstructive Sleep Apnea & Its Role in Excessive Daytime Sleepiness

• • 

    

    Paul Doghramji, MD

    Peer

  1

  

  RestartResume

  Challenges in Identifying, Assessing, & Monitoring Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Richard K. Bogan, MD

    Peer

  1

  

  RestartResume

  Prevalence of Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Jessica Ailani, MD

    Peer

  0

  

  RestartResume

  Adverse Event Detection & Reporting: What Healthcare Providers Need to Know

• 1
• 2
• 3
• …
• 6
• 7
• Next